STOCK TITAN

[144] AllianceBernstein Holding, L.P. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for proposed sale of common stock. The filing reports an intended sale of 31,694 shares of common stock with an aggregate market value of $1,281,705.00. The securities represent shares acquired on 12/04/2023 through vesting/deferred compensation. The filer lists 110,537,295 shares outstanding and an approximate sale date of 08/19/2025 on the NYSE. The broker name and address shown is "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." The filing indicates no securities sold in the past three months and includes the standard signer representation about absence of undisclosed material adverse information.

Avviso Modulo 144 per proposta vendita di azioni ordinarie. La comunicazione segnala l'intenzione di vendere 31.694 azioni ordinarie per un valore di mercato complessivo di $1.281.705,00. Le azioni sono state acquisite il 04/12/2023 mediante maturazione/compenso differito. Il dichiarante riporta 110.537.295 azioni in circolazione e una data approssimativa di vendita il 19/08/2025 sul NYSE. Il broker indicato è "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." La comunicazione dichiara l'assenza di vendite negli ultimi tre mesi e include la consueta dichiarazione del firmatario relativa all'assenza di informazioni materiali indescluse.

Aviso del Formulario 144 sobre propuesta de venta de acciones ordinarias. La presentación informa la intención de vender 31.694 acciones ordinarias por un valor de mercado agregado de $1.281.705,00. Los títulos fueron adquiridos el 04/12/2023 mediante vesting/compensación diferida. El declarante indica 110.537.295 acciones en circulación y una fecha aproximada de venta el 19/08/2025 en el NYSE. El corredor y dirección registrados son "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." La presentación señala que no hubo valores vendidos en los últimos tres meses e incluye la representación habitual del firmante sobre la ausencia de información material no divulgada.

보통주 매도 예정에 대한 Form 144 통지. 제출서에는 총 시가가 $1,281,705.0031,694주의 보통주를 매도할 예정임이 보고되어 있습니다. 해당 유가는 2023-12-04에 베스팅/지급유예 방식으로 취득된 주식입니다. 제출인은 발행 주식 수를 110,537,295주로 기재했으며, 매도 예정일은 2025-08-19로 NYSE에서의 거래를 예상하고 있습니다. 기재된 중개인 명칭 및 주소는 "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262."입니다. 제출서에는 지난 3개월간 매도 내역이 없음을 명시하며, 공시되지 않은 중대한 불리한 정보가 없다는 서명인의 통상적 진술을 포함하고 있습니다.

Avis Formulaire 144 concernant la vente projetée d'actions ordinaires. Le dépôt signale l'intention de vendre 31 694 actions ordinaires pour une valeur marchande totale de $1 281 705,00. Les titres ont été acquis le 04/12/2023 par vesting/compensation différée. Le déclarant indique 110 537 295 actions en circulation et une date approximative de vente le 19/08/2025 sur le NYSE. Le courtier et son adresse figurent comme "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." Le dépôt précise qu'aucun titre n'a été vendu au cours des trois derniers mois et inclut la déclaration habituelle du signataire concernant l'absence d'informations défavorables matérielles non divulguées.

Formular 144-Hinweis für geplanten Verkauf von Stammaktien. Die Einreichung meldet den geplanten Verkauf von 31.694 Stammaktien mit einem Gesamtkurswert von $1.281.705,00. Die Wertpapiere wurden am 04.12.2023 durch Vesting/aufgeschobene Vergütung erworben. Der Meldende gibt 110.537.295 ausstehende Aktien an und einen ungefähren Verkaufstermin am 19.08.2025 an der NYSE. Als Broker und Adresse ist "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." angegeben. Die Meldung vermerkt keine Verkäufe in den vergangenen drei Monaten und enthält die übliche Unterzeichnererklärung über das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen.

Positive
  • Clear compliance with Rule 144 disclosure requirements: acquisition date, nature, and planned sale date are provided
  • No sales in past three months, which reduces aggregation concerns under Rule 144
Negative
  • None.

Insights

TL;DR: Routine insider sale notice of vested compensation shares; size is small relative to total outstanding and appears procedural.

The filing notifies the SEC of a proposed sale of 31,694 common shares valued at $1.28 million, acquired via vesting/deferred compensation on 12/04/2023. With 110.5 million shares outstanding, the position represents roughly 0.03% of outstanding stock, indicating the transaction is unlikely to be materially dilutive or market-moving. The notice shows no related sales in the prior three months and uses a common broker designation. This is a standard Rule 144 disclosure rather than an operational or financial update.

TL;DR: Compliance-focused disclosure consistent with insider selling rules; signer affirms no undisclosed material information.

The form documents compliance with Rule 144 for the proposed disposition of shares acquired as deferred compensation. The attestation about lacking undisclosed material adverse information is standard and the absence of recent sales reduces concerns about aggregated disposition patterns. There is no indication in the filing of any governance or policy changes; it functions primarily as regulatory notice of a planned sale.

Avviso Modulo 144 per proposta vendita di azioni ordinarie. La comunicazione segnala l'intenzione di vendere 31.694 azioni ordinarie per un valore di mercato complessivo di $1.281.705,00. Le azioni sono state acquisite il 04/12/2023 mediante maturazione/compenso differito. Il dichiarante riporta 110.537.295 azioni in circolazione e una data approssimativa di vendita il 19/08/2025 sul NYSE. Il broker indicato è "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." La comunicazione dichiara l'assenza di vendite negli ultimi tre mesi e include la consueta dichiarazione del firmatario relativa all'assenza di informazioni materiali indescluse.

Aviso del Formulario 144 sobre propuesta de venta de acciones ordinarias. La presentación informa la intención de vender 31.694 acciones ordinarias por un valor de mercado agregado de $1.281.705,00. Los títulos fueron adquiridos el 04/12/2023 mediante vesting/compensación diferida. El declarante indica 110.537.295 acciones en circulación y una fecha aproximada de venta el 19/08/2025 en el NYSE. El corredor y dirección registrados son "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." La presentación señala que no hubo valores vendidos en los últimos tres meses e incluye la representación habitual del firmante sobre la ausencia de información material no divulgada.

보통주 매도 예정에 대한 Form 144 통지. 제출서에는 총 시가가 $1,281,705.0031,694주의 보통주를 매도할 예정임이 보고되어 있습니다. 해당 유가는 2023-12-04에 베스팅/지급유예 방식으로 취득된 주식입니다. 제출인은 발행 주식 수를 110,537,295주로 기재했으며, 매도 예정일은 2025-08-19로 NYSE에서의 거래를 예상하고 있습니다. 기재된 중개인 명칭 및 주소는 "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262."입니다. 제출서에는 지난 3개월간 매도 내역이 없음을 명시하며, 공시되지 않은 중대한 불리한 정보가 없다는 서명인의 통상적 진술을 포함하고 있습니다.

Avis Formulaire 144 concernant la vente projetée d'actions ordinaires. Le dépôt signale l'intention de vendre 31 694 actions ordinaires pour une valeur marchande totale de $1 281 705,00. Les titres ont été acquis le 04/12/2023 par vesting/compensation différée. Le déclarant indique 110 537 295 actions en circulation et une date approximative de vente le 19/08/2025 sur le NYSE. Le courtier et son adresse figurent comme "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." Le dépôt précise qu'aucun titre n'a été vendu au cours des trois derniers mois et inclut la déclaration habituelle du signataire concernant l'absence d'informations défavorables matérielles non divulguées.

Formular 144-Hinweis für geplanten Verkauf von Stammaktien. Die Einreichung meldet den geplanten Verkauf von 31.694 Stammaktien mit einem Gesamtkurswert von $1.281.705,00. Die Wertpapiere wurden am 04.12.2023 durch Vesting/aufgeschobene Vergütung erworben. Der Meldende gibt 110.537.295 ausstehende Aktien an und einen ungefähren Verkaufstermin am 19.08.2025 an der NYSE. Als Broker und Adresse ist "THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262." angegeben. Die Meldung vermerkt keine Verkäufe in den vergangenen drei Monaten und enthält die übliche Unterzeichnererklärung über das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for AB (AllianceBernstein) report?

The filing reports a proposed sale of 31,694 common shares with an aggregate market value of $1,281,705.00, approximate sale date 08/19/2025.

When and how were the shares to be sold acquired?

The shares were acquired on 12/04/2023 as vesting/deferred compensation.

How many shares outstanding does the filing report?

The filing lists 110,537,295 shares outstanding.

Which broker is named on the Form 144?

The broker listed is THE CHARLES SCHWAB CORPORATION, 3000 Schwab Way, Westlake TX 76262.

Were there any securities sold by the filer in the past three months?

The filing states Nothing to Report for securities sold during the past three months.
Alliancebernstein Hldg L P

NYSE:AB

AB Rankings

AB Latest News

AB Latest SEC Filings

AB Stock Data

4.40B
108.86M
1.76%
12.66%
0.29%
Asset Management
Investment Advice
Link
United States
NASHVILLE